SLDB - Solid Biosciences Inc.

Insider Sale by Howton David T (COO)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

4 days ago, Howton David T, serving as COO at Solid Biosciences Inc. (SLDB), sold 7,469 shares at $5.82 per share, for a total transaction value of $43,494.00. Following this transaction, Howton David T now holds 105,077 shares of SLDB.

This sale represents a 7.00% decrease in Howton David T's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, February 18, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 18, 2026, meaning the disclosure happened on the same day as the trade.

Solid Biosciences Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Howton David T

COO

David T. Howton, Jr. (also known as Ty Howton) is the Chief Operating Officer at Solid Biosciences Inc. (SLDB), a clinical-stage biotechnology company developing gene therapies for Duchenne muscular dystrophy.[[1]](https://www.solidbio.com/solid-team/ty-howton/)[[2]](https://au.marketscreener.com/insider/TY-HOWTON-A028G3/)[[5]](https://www.marketbeat.com/instant-alerts/david-howton-sells-18894-shares-of-solid-biosciences-nasdaqsldb-stock-2026-02-06/) He has served in this role since September 2023, after acting as Chief Administrative Officer from December 2022, and leads corporate functions including program management, legal, and human resources.[[1]](https://www.solidbio.com/solid-team/ty-howton/)[[8]](https://www.solidbio.com/about/solid-team/management/) Howton brings extensive experience in biotechnology legal and operational leadership. Previously, he was Chief Operating Officer and General Counsel at AavantiBio from March 2021 to December 2022; Executive Vice President, General Counsel, and Corporate Secretary at Sarepta Therapeutics from November 2012 to December 2020; Senior Vice President, Chief Legal Officer, and Chief Compliance Officer at Vertex Pharmaceuticals until 2012; and held multiple legal roles at Genentech.[[1]](https://www.solidbio.com/solid-team/ty-howton/)[[2]](https://au.marketscreener.com/insider/TY-HOWTON-A028G3/)[[4]](https://www.gurufocus.com/insider/5615/david-t-howton) He earned a Bachelor of Arts in Political Science from Yale University and a Juris Doctor from Northwestern University School of Law, and serves on the board of Make-A-Wish Massachusetts and Rhode Island since March 2021.[[1]](https://www.solidbio.com/solid-team/ty-howton/)[[2]](https://au.marketscreener.com/insider/TY-HOWTON-A028G3/) As a corporate insider, Howton has recently sold shares in SLDB, including 18,894 shares on February 4, 2026, and 37,771 shares on February 2, 2026.[[3]](https://www.sahmcapital.com/news/content/solid-biosciences-coo-david-t-howton-reports-disposal-of-common-shares-2026-02-07)[[5]](https://www.marketbeat.com/instant-alerts/david-howton-sells-18894-shares-of-solid-biosciences-nasdaqsldb-stock-2026-02-06/)[[7]](https://www.investing.com/news/insider-trading-news/solid-biosciences-coo-howton-sells-243k-in-shares-93CH-4480492)

View full insider profile →

Trade Price

$5.82

Quantity

7,469

Total Value

$43,494.00

Shares Owned

105,077

Trade Date

Wednesday, February 18, 2026

4 days ago

SEC Filing Date

Wednesday, February 18, 2026

HEALTHCAREBIOTECHNOLOGY

About Solid Biosciences Inc.

Company Overview

No company information available
View news mentioning SLDB

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4102153

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime